{"data":{"id":719,"lang":"en","title":"Psilocybin Gives Smokers Six Times Greater Odds of Quitting Than Nicotine Patches, Johns Hopkins Study Finds","summary":"Johns Hopkins study finds psilocybin gives smokers 6x greater odds of quitting than nicotine patches in JAMA Network Open trial.","category":"science","category_label":"Science","published_at":"2026-03-11T12:01:50Z","updated_at":"2026-03-11T12:01:50Z","url":"https://techtools.cz/tools/news/article/719-psilocybin-gives-smokers-six-times-greater-odds-of-quitting-than-nicotine","api_url":"https://techtools.cz/news-api/v1/articles/719?lang=en","markdown_url":"https://techtools.cz/news-api/v1/articles/719.md?lang=en","image_url":"https://npr.brightspotcdn.com/dims3/default/strip/false/crop/1024x768+0+0/resize/1024x768!/?url=http%3A%2F%2Fnpr-brightspot.s3.amazonaws.com%2F99%2F2d%2F70f3c41b4df9a2e5c60c807c1083%2Fgettyimages-1576462600.jpg","word_count":157,"reading_time_minutes":1,"sources":[{"url":"https://www.npr.org/2026/03/10/nx-s1-5742457/psilocybin-magic-mushroom-quit-smoking","domain":"npr.org"},{"url":"https://www.opb.org/article/2026/03/10/psilocybin-may-help-people-quit-smoking-new-research-finds/","domain":"opb.org"}],"translation":{"lang":"cs","id":734,"title":"Psilocybin dává kuřákům šestinásobně vyšší šanci přestat kouřit než nikotinové náplasti, zjistila studie Johns Hopkins","url":"https://techtools.cz/tools/news/clanek/734-psilocybin-dava-kurakum-sestinasobne-vyssi-sanci-prestat-kourit-nez-nikotinove","api_url":"https://techtools.cz/news-api/v1/articles/734?lang=cs"},"content":"A new study published in JAMA Network Open found that psilocybin gave smokers more than six times greater odds of quitting compared to nicotine patches. In the trial of 82 smokers at Johns Hopkins University, 17 participants in the psilocybin group remained abstinent at six months versus just 4 in the nicotine patch group.\n\nLead researcher Matthew Johnson, a professor of psychiatry at Johns Hopkins, said he was \"surprised by the sheer magnitude of the effect.\" Unlike traditional smoking cessation drugs, psilocybin does not target nicotine receptors — instead, researchers believe it harnesses neuroplastic and learning effects that reshape addictive behavior patterns. All participants also received 13 weeks of cognitive behavioral therapy.\n\nThe results have prompted the National Institutes of Health to fund a larger follow-up trial with a placebo arm. Smoking cessation expert Megan Piper noted that typical quit rates with medication and counseling range between 20% to 30% per attempt, making the psilocybin results particularly striking."}}